Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Project Information

INCENTIVE

Grant agreement ID: 874866

DOI 10.3030/874866

EC signature date 13 December 2019

Start date 1 August 2020

End date 31 July 2025

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 19 965 992,50

EU contribution € 9 974 293,75

Coordinated by

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Germany

Deliverables

Websites, patent fillings, videos etc. (1)

Project presentation prepared, website launched and communication plan developed

Setting up consortium website public and secured intranet Communication plan regulating the consortium communication

Documents, reports (1)

INCENTIVE-QIV: Registration of the clinical trial in the trial registry

Study registered at a WHO or ICMJapproved registry

Publications

Peer reviewed articles (10)

SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.

Author(s): Trieu, Mai-Chi; Bansal, Amit; Madsen, Anders; Zhou, Fan; Sævik, Marianne; Vahokoski, Juha; Brokstad, Karl Albert; Krammer, Florian; Tøndel, Camilla; Mohn, Kristin G I; Blomberg, Bjørn; Langeland, Nina; Cox, Rebecca J; Kittang, Bård; Linchausen, Dagrunn Waag; Amdam, Håkon; Onyango, Therese Bredholt; Bredholt, Geir; Ertesvåg, Nina; Lartey, Sarah; Sandnes, Helene Heitmann; Grøvan, Fredrik; Bar
Published in: The Journal of Infectious Diseases, Issue 1, 2020, ISSN 0022-1899
Publisher: University of Chicago Press
DOI: 10.1093/infdis/jiaa737

Next Generation Influenza Vaccines: Looking into theCrystal Ball

Author(s): Carlos Alberto Guzmán
Published in: Vaccines, 2020, ISSN 2076-393X
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines8030464

Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.

Author(s): Kristin G-I, Mohn; Geir, Bredholt; Fan, Zhou; Anders, Madsen; Therese B, Onyango; Elisabeth B, Fjelltveit; Sarah L, Jalloh; Karl A, Brokstad; Diego, Cantoni; Martin, Mayora-Neto; Nigel, Temperton; Nina, Langeland; Rebecca J, Cox
Published in: PLoS ONE, 2022, ISSN 1932-6203
Publisher: Public Library of Science
DOI: 10.1371/journal.pone.0261979

Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection

Author(s): Fan Zhou; Lena Hansen; Gabriel K. Pedersen; Gabriel K. Pedersen; Gunnveig Grødeland; Rebecca Jane Cox; Rebecca Jane Cox
Published in: Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection, 2021, ISSN 1664-3224
Publisher: Lausanne: Frontiers Media S.A
DOI: 10.3389/fimmu.2021.747774

Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review.

Author(s): Amit Bansal; Mai-Chi Trieu; Kristin G.-I. Mohn; Kristin G.-I. Mohn; Rebecca Jane Cox; Rebecca Jane Cox
Published in: Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review, 2021, ISSN 1664-3224
Publisher: Lausanne: Frontiers Media S.A
DOI: 10.3389/fimmu.2021.744774

Prospects and challenges in the development of universal influenza vaccines

Author(s): Anders Madsen; Rebecca Jane Cox; Rebecca Jane Cox
Published in: Prospects and Challenges in the Development of Universal Influenza Vaccines, 2020, ISSN 2076-393X
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines8030361

Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults.

Author(s): Elisabeth B. Fjelltveit; Elisabeth B. Fjelltveit; Rebecca Jane Cox; Rebecca Jane Cox; J Østensjø; Bjørn Blomberg; Bjørn Blomberg; M H Ebbesen; Nina Langeland; K G-I Mohn; K G-I Mohn
Published in: The Journal of Infectious Diseases, Issue 1, 2020, ISSN 0022-1899
Publisher: University of Chicago Press
DOI: 10.1093/infdis/jiaa690

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern

Author(s): Ertesvåg, Nina Urke; Xiao, Julie; Zhou, Fan; Ljostveit, Sonja; Sandnes, Helene; Lartey, Sarah; Sævik, Marianne; Hansen, Lena; Madsen, Anders; Mohn, Kristin G. I.; Fjelltveit, Elisabeth; Olofsson, Jan Stefan; Tan, Tiong Kit; Rijal, Pramila; Schimanski, Lisa; Øyen, Siri; Brokstad, Karl Albert; Dunachie, Susanna; Jämsén, Anni; James, William S.; Harding, Adam C.; Harvala, Heli; Nguyen, Dung; Rob
Published in: Communications Medicine, Issue 1, 2022, ISSN 2730-664X
Publisher: Springer Nature
DOI: 10.1038/s43856-022-00091-x

Long COVID affects home-isolated young patients

Author(s): Bjørn Blomberg; Kristin G.-I. Mohn; Karl A. Brokstad; Dagrunn Waag Linchausen; Bent-Are Hansen; Sarah Lartey Jalloh; Kanika Kuwelker; Fan Zhou; Marianne Sævik; Hauke Bartsch; Camilla Tøndel; Bård Reiakvam Kittang; Rebecca Jane Cox; Nina Langeland
Published in: Long COVID in a prospective cohort of home-isolated patients, 2021, ISSN 1078-8956
Publisher: Nature Publishing Group
DOI: 10.21203/rs.3.rs-238339/v1

Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies

Author(s): Anette S.B. Wolff; Lena Hansen; Marianne Aa. Grytaas; Bergithe E. Oftedal; Lars Breivik; Fan Zhou; Karl Ove Hufthammer; Thea Sjøgren; Jan Stefan Olofsson; Mai Chi Trieu; Anthony Meager; Anders P. Jørgensen; Kari Lima; Kristin Greve-Isdahl Mohn; Nina Langeland; Rebecca Jane Cox; Eystein S. Husebye
Published in: Crossref, Issue 1, 2023, ISSN 2589-0042
Publisher: Cell Press
DOI: 10.1016/j.isci.2023.107084